ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

National Taiwan University Cancer Center at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

National Taiwan University Cancer Center takes part in 4 sessions at ESMO 2026 in Madrid. Its work focuses on lung and digestive cancers, including tumour changes during treatment and responses to immunotherapy. It examines how c-MET, HER2, TROP2 and TP53 expression changes during EGFR treatment, alongside studies of liver and esophageal cancers.

OrganizationESMO 2026 Attendance
Cancer centre & hospital
Cancer center of National Taiwan University in Taipei City, Taiwan.
Poster
Fri Oct 23
13:00–15:00
Longitudinal dynamics of c-MET, HER2, TROP2, and TP53 expression in EGFR-mutant NSCLC under first-line EGFR-TKI treatment
ePoster session 14
Lung & thoracic cancersBiomarkers & precision oncology
Poster
Fri Oct 23
13:00–15:00
Multiomic dissection of response-to-escape transition in mismatch repair–deficient hepatocellular carcinoma treated with immunotherapy
ePoster session 9
Gastrointestinal cancersBiomarkers & precision oncology

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at National Taiwan University Cancer Center

Tell us what you sell and we’ll find the people at National Taiwan University Cancer Center most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction